(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Xenetic Biosciences, Pacific Biosciences of California, and Sundial Growers.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Xenetic Biosciences (XBIO) 1.19 4.39% 2022-04-14 04:19:38
2 Pacific Biosciences of California (PACB) 8.40 3.07% 2022-04-14 04:14:07
3 Sundial Growers (SNDL) 0.61 2.73% 2022-04-14 07:32:53
4 Ambev (ABEV) 3.22 2.55% 2022-04-14 04:09:18
5 TherapeuticsMD (TXMD) 0.31 1.69% 2022-04-14 07:33:17
6 Sorrento Therapeutics (SRNE) 2.06 1.48% 2022-04-14 04:15:05
7 ING Group (ING) 10.38 1.47% 2022-04-14 04:14:33
8 The AES (AES) 24.80 1.35% 2022-04-14 04:09:24
9 Fastenal Company (FAST) 59.57 1% 2022-04-14 04:11:14
10 Kodak (KODK) 6.13 0.99% 2022-04-14 04:15:13

The three most active and biggest losers today are Banco Bilbao Vizcaya Argentaria, Vodafone, and Lumen Technologies.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Banco Bilbao Vizcaya Argentaria (BBVA) 5.29 -1.67% 2022-04-14 04:20:48
2 Vodafone (VOD) 17.45 -0.63% 2022-04-14 07:00:40
3 Lumen Technologies (LUMN) 11.50 -0.52% 2022-04-14 04:36:50
4 Toyota (TM) 167.66 -0.46% 2022-04-14 04:44:33
5 Wipro Limited (WIT) 7.10 -0.42% 2022-04-14 04:20:37
6 Geo Group (GEO) 6.31 -0.32% 2022-04-14 05:44:18
7 Broadcom (AVGOP) 1850.96 -0.25% 2022-04-14 04:16:29
8 Mondelez International (MDLZ) 63.70 -0.23% 2022-04-14 04:13:16
9 Royalty Pharma (RPRX) 42.35 -0.21% 2022-04-14 04:14:36
10 Freeport (FCX) 49.35 -0.16% 2022-04-14 04:13:11

Most Active Premarket Winners today

1. Xenetic Biosciences (XBIO) – Premarket: 4.39%

NASDAQ ended the session with Xenetic Biosciences rising 5.56% to $1.14 on Thursday while NASDAQ jumped 2.03% to $13,643.59.

Volume

Today’s last reported volume for Xenetic Biosciences is 980426, 710.83% above its average volume of 120916.

Xenetic Biosciences’s last close was $1.14, 79.93% below its 52-week high of $5.68.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the present quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 2.33%, 0.88%, and 3.29%, respectively.

Xenetic Biosciences’s highest amplitude of average volatility was 2.58% (last week), 3.20% (last month), and 3.29% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be oversold (<=20).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $1.14 at 08:34 EST, under its 52-week low of $1.21.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s worth is way under its 50-day moving average of $1.64 and way under its 200-day moving average of $2.19.

More news about Xenetic Biosciences.

2. Pacific Biosciences of California (PACB) – Premarket: 3.07%

NASDAQ ended the session with Pacific Biosciences of California jumping 0.31% to $8.15 on Thursday, following the last session’s upward trend. NASDAQ jumped 2.03% to $13,643.59, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 4916500, 12.98% below its average volume of 5650240.

Pacific Biosciences of California’s last close was $8.15, 77.59% below its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 33.8% for the present quarter and 48.3% for the next. The company’s growth estimates for the current quarter is a negative 178.4% and positive 40% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.18%, a negative 1.12%, and a positive 5.25%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 2.29% (last week), 5.22% (last month), and 5.25% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be overbought (>=80).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $8.15 at 08:34 EST, under its 52-week low of $8.26.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $10.50 and way below its 200-day moving average of $21.75.

More news about Pacific Biosciences of California.

3. Sundial Growers (SNDL) – Premarket: 2.73%

NASDAQ ended the session with Sundial Growers jumping 3.53% to $0.59 on Thursday while NASDAQ jumped 2.03% to $13,643.59.

Volume

Today’s last reported volume for Sundial Growers is 54041600, 46.04% below its average volume of 100160000.

Sundial Growers’s last close was $0.59, 85.03% below its 52-week high of $3.96.

Sundial Growers’s Sales

Sundial Growers’s sales growth is 28.9% for the ongoing quarter and 21.7% for the next. The company’s growth estimates for the present quarter and the next is 100% and 100%, respectively.

Sundial Growers’s Revenue

Year-on-year quarterly revenue growth declined by 54.7%, now sitting on 45.76M for the twelve trailing months.

Volatility

Sundial Growers’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.19%, a positive 1.11%, and a positive 4.59%, respectively.

Sundial Growers’s highest amplitude of average volatility was 2.25% (last week), 5.05% (last month), and 4.59% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sundial Growers’s stock is considered to be oversold (<=20).

Sundial Growers’s Stock Yearly Top and Bottom Value

Sundial Growers’s stock is valued at $0.59 at 08:34 EST, way under its 52-week high of $3.96 and way above its 52-week low of $0.42.

Sundial Growers’s Moving Average

Sundial Growers’s worth is way below its 50-day moving average of $0.67 and way below its 200-day moving average of $0.86.

More news about Sundial Growers.

4. Ambev (ABEV) – Premarket: 2.55%

NYSE ended the session with Ambev sliding 2.18% to $3.14 on Thursday while NYSE rose 0.9% to $16,614.79.

Volume

Today’s last reported volume for Ambev is 21430400, 12.95% below its average volume of 24620400.

Ambev’s last close was $2.60, 34.18% under its 52-week high of $3.95.

Ambev’s Sales

Ambev’s sales growth is 9.9% for the ongoing quarter and 2.3% for the next.

Ambev’s Revenue

Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 72.85B for the twelve trailing months.

Ambev’s Stock Yearly Top and Bottom Value

Ambev’s stock is valued at $3.14 at 08:34 EST, way below its 52-week high of $3.95 and way above its 52-week low of $2.50.

Ambev’s Moving Average

Ambev’s worth is higher than its 50-day moving average of $2.88 and higher than its 200-day moving average of $2.96.

More news about Ambev.

5. TherapeuticsMD (TXMD) – Premarket: 1.69%

NASDAQ ended the session with TherapeuticsMD rising 0.37% to $0.30 on Thursday while NASDAQ rose 2.03% to $13,643.59.

Volume

Today’s last reported volume for TherapeuticsMD is 2646070, 61.82% below its average volume of 6931720.

TherapeuticsMD’s last close was $0.30, 89.03% below its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.30 at 08:34 EST, way below its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way under its 50-day moving average of $0.66 and way below its 200-day moving average of $1.00.

More news about TherapeuticsMD.

6. Sorrento Therapeutics (SRNE) – Premarket: 1.48%

NASDAQ ended the session with Sorrento Therapeutics jumping 1.25% to $2.03 on Thursday while NASDAQ rose 2.03% to $13,643.59.

Volume

Today’s last reported volume for Sorrento Therapeutics is 6942520, 21.47% below its average volume of 8841020.

Sorrento Therapeutics’s last close was $2.03, 81.66% under its 52-week high of $11.07.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 13% for the ongoing quarter and 149% for the next. The company’s growth estimates for the current quarter is 14.8% and a drop 1800% for the next.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 51.33M for the twelve trailing months.

Volatility

Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.51%, a negative 0.34%, and a positive 4.25%, respectively.

Sorrento Therapeutics’s highest amplitude of average volatility was 2.33% (last week), 3.58% (last month), and 4.25% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be oversold (<=20).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.03 at 08:34 EST, way under its 52-week high of $11.07 and higher than its 52-week low of $1.96.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is way below its 50-day moving average of $2.62 and way below its 200-day moving average of $5.93.

More news about Sorrento Therapeutics.

7. ING Group (ING) – Premarket: 1.47%

NYSE ended the session with ING Group jumping 2.2% to $10.23 on Thursday while NYSE rose 0.9% to $16,614.79.

Volume

Today’s last reported volume for ING Group is 9535540, 27.58% above its average volume of 7473900.

ING Group’s last close was $9.35, 41.45% below its 52-week high of $15.97.

ING Group’s Revenue

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 17.97B for the twelve trailing months.

ING Group’s Stock Yearly Top and Bottom Value

ING Group’s stock is valued at $10.23 at 08:34 EST, way under its 52-week high of $15.97 and way higher than its 52-week low of $8.97.

ING Group’s Moving Average

ING Group’s value is way under its 50-day moving average of $12.49 and way under its 200-day moving average of $13.61.

More news about ING Group.

8. The AES (AES) – Premarket: 1.35%

NYSE ended the session with The AES jumping 0.08% to $24.47 on Thursday while NYSE rose 0.9% to $16,614.79.

Volume

Today’s last reported volume for The AES is 3373300, 46.81% below its average volume of 6342150.

The AES’s last close was $22.20, 23.08% under its 52-week high of $28.86.

The AES’s Sales

The AES’s sales growth is 7% for the present quarter and a decline by 4.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 6.2% and positive 17.9% for the next.

The AES’s Revenue

Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 10.93B for the twelve trailing months.

The AES’s Stock Yearly Top and Bottom Value

The AES’s stock is valued at $24.47 at 08:34 EST, way below its 52-week high of $28.86 and way above its 52-week low of $19.76.

The AES’s Moving Average

The AES’s worth is higher than its 50-day moving average of $22.79 and above its 200-day moving average of $23.86.

More news about The AES.

9. Fastenal Company (FAST) – Premarket: 1%

NASDAQ ended the session with Fastenal Company jumping 2.24% to $58.98 on Thursday while NASDAQ jumped 2.03% to $13,643.59.

Volume

Today’s last reported volume for Fastenal Company is 4202690, 17.19% above its average volume of 3585980.

Fastenal Company’s last close was $58.98, 8.91% under its 52-week high of $64.75.

Fastenal Company’s Sales

Fastenal Company’s sales growth is 10% for the present quarter and 12.9% for the next. The company’s growth estimates for the present quarter and the next is 8.8% and 13.5%, respectively.

Fastenal Company’s Revenue

Year-on-year quarterly revenue growth grew by 10%, now sitting on 5.84B for the twelve trailing months.

Volatility

Fastenal Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.12%, 0.58%, and 1.24%, respectively.

Fastenal Company’s highest amplitude of average volatility was 1.25% (last week), 1.19% (last month), and 1.24% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fastenal Company’s stock is considered to be oversold (<=20).

Fastenal Company’s Stock Yearly Top and Bottom Value

Fastenal Company’s stock is valued at $58.98 at 08:34 EST, below its 52-week high of $64.75 and way above its 52-week low of $48.57.

Fastenal Company’s Moving Average

Fastenal Company’s worth is above its 50-day moving average of $55.20 and higher than its 200-day moving average of $56.37.

More news about Fastenal Company.

10. Kodak (KODK) – Premarket: 0.99%

NYSE ended the session with Kodak sliding 1.46% to $6.07 on Thursday, after two consecutive sessions in a row of losses. NYSE rose 0.9% to $16,614.79, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Kodak is 1064720, 43.69% below its average volume of 1891080.

Kodak’s last close was $4.46, 60.39% below its 52-week high of $11.26.

Kodak’s Revenue

Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.14B for the twelve trailing months.

Kodak’s Stock Yearly Top and Bottom Value

Kodak’s stock is valued at $6.07 at 08:34 EST, way below its 52-week high of $11.26 and way above its 52-week low of $3.46.

Kodak’s Moving Average

Kodak’s value is way higher than its 50-day moving average of $5.12 and below its 200-day moving average of $6.19.

More news about Kodak.

Most Active Premarket Losers Today

1. Banco Bilbao Vizcaya Argentaria (BBVA) – Premarket: -1.67%

NYSE ended the session with Banco Bilbao Vizcaya Argentaria rising 0.66% to $5.38 on Thursday while NYSE jumped 0.9% to $16,614.79.

Volume

Today’s last reported volume for Banco Bilbao Vizcaya Argentaria is 1349490, 58.57% below its average volume of 3257820.

Banco Bilbao Vizcaya Argentaria’s last close was $5.38, 25.9% below its 52-week high of $7.26.

Banco Bilbao Vizcaya Argentaria’s Revenue

Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 16.1B for the twelve trailing months.

Volatility

Banco Bilbao Vizcaya Argentaria’s last week, last month’s, and last quarter’s current intraday variation average was 0.19%, 0.09%, and 2.35%, respectively.

Banco Bilbao Vizcaya Argentaria’s highest amplitude of average volatility was 0.60% (last week), 2.16% (last month), and 2.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Banco Bilbao Vizcaya Argentaria’s stock is considered to be oversold (<=20).

Banco Bilbao Vizcaya Argentaria’s Stock Yearly Top and Bottom Value

Banco Bilbao Vizcaya Argentaria’s stock is valued at $5.38 at 08:34 EST, way below its 52-week high of $7.26 and way higher than its 52-week low of $4.53.

Banco Bilbao Vizcaya Argentaria’s Moving Average

Banco Bilbao Vizcaya Argentaria’s worth is way under its 50-day moving average of $6.41 and way under its 200-day moving average of $6.18.

More news about Banco Bilbao Vizcaya Argentaria.

2. Vodafone (VOD) – Premarket: -0.63%

NASDAQ ended the session with Vodafone jumping 2.51% to $17.56 on Thursday while NASDAQ jumped 2.03% to $13,643.59.

Volume

Today’s last reported volume for Vodafone is 7138620, 7.35% above its average volume of 6649520.

Vodafone’s last close was $17.56, 13.75% below its 52-week high of $20.36.

Vodafone’s Revenue

Year-on-year quarterly revenue growth grew by 5%, now sitting on 44.87B for the twelve trailing months.

Volatility

Vodafone’s last week, last month’s, and last quarter’s current intraday variation average was 0.82%, 0.48%, and 1.47%, respectively.

Vodafone’s highest amplitude of average volatility was 0.82% (last week), 1.18% (last month), and 1.47% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Vodafone’s stock is considered to be oversold (<=20).

Vodafone’s Stock Yearly Top and Bottom Value

Vodafone’s stock is valued at $17.56 at 08:34 EST, way below its 52-week high of $20.36 and way higher than its 52-week low of $14.53.

Vodafone’s Moving Average

Vodafone’s worth is higher than its 50-day moving average of $17.32 and above its 200-day moving average of $16.31.

More news about Vodafone.

3. Lumen Technologies (LUMN) – Premarket: -0.52%

NYSE ended the session with Lumen Technologies rising 1.36% to $11.56 on Thursday, after two consecutive sessions in a row of gains. NYSE rose 0.9% to $16,614.79, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Lumen Technologies is 5273050, 65.44% below its average volume of 15257700.

Lumen Technologies’s last close was $10.68, 35.66% below its 52-week high of $16.60.

Lumen Technologies’s Sales

Lumen Technologies’s sales growth is a negative 4.6% for the present quarter and a decline by 4.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 5% and a negative 18.7%, respectively.

Lumen Technologies’s Revenue

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 20.25B for the twelve trailing months.

Lumen Technologies’s Stock Yearly Top and Bottom Value

Lumen Technologies’s stock is valued at $11.56 at 08:34 EST, way under its 52-week high of $16.60 and way above its 52-week low of $9.46.

Lumen Technologies’s Moving Average

Lumen Technologies’s worth is below its 50-day moving average of $12.65 and way under its 200-day moving average of $13.07.

More news about Lumen Technologies.

4. Toyota (TM) – Premarket: -0.46%

NYSE ended the session with Toyota jumping 1.64% to $168.44 on Thursday, after three sequential sessions in a row of gains. NYSE rose 0.9% to $16,614.79, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Toyota is 248768, 22.46% below its average volume of 320827.

Toyota’s last close was $168.44, 10.49% under its 52-week high of $188.18.

Toyota’s Revenue

Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 31.32T for the twelve trailing months.

Volatility

Toyota’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.06%, a positive 0.31%, and a positive 1.63%, respectively.

Toyota’s highest amplitude of average volatility was 1.71% (last week), 1.56% (last month), and 1.63% (last quarter), respectively.

Toyota’s Stock Yearly Top and Bottom Value

Toyota’s stock is valued at $168.44 at 08:34 EST, way under its 52-week high of $188.18 and way above its 52-week low of $139.29.

Toyota’s Moving Average

Toyota’s worth is under its 50-day moving average of $179.03 and below its 200-day moving average of $171.61.

Previous days news about Toyota

  • Toyota debuts bz4x SUV battery electric vehicle. According to Benzinga on Tuesday, 12 April, "What Happened: The bZ4X is the first Toyota vehicle to be launched under the global bZ (Beyond Zero) series of battery electric vehicles (BEVs). ", "Why It Happened: Toyota is planning to release roughly around 70 electrified models globally by 2025, with 15 dedicated BEVs including seven carrying the bZ brand."

More news about Toyota.

5. Wipro Limited (WIT) – Premarket: -0.42%

NYSE ended the session with Wipro Limited sliding 1.11% to $7.13 on Thursday, after four sequential sessions in a row of losses. NYSE jumped 0.9% to $16,614.79, following the last session’s upward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Wipro Limited is 2493100, 28.85% below its average volume of 3504080.

Wipro Limited’s last close was $7.54, 24.3% below its 52-week high of $9.96.

Wipro Limited’s Revenue

Year-on-year quarterly revenue growth grew by 3.4%, now sitting on 619.43B for the twelve trailing months.

Wipro Limited’s Stock Yearly Top and Bottom Value

Wipro Limited’s stock is valued at $7.13 at 08:34 EST, way below its 52-week high of $9.96 and way higher than its 52-week low of $4.96.

Wipro Limited’s Moving Average

Wipro Limited’s worth is way under its 50-day moving average of $9.20 and way below its 200-day moving average of $8.50.

More news about Wipro Limited.

6. Geo Group (GEO) – Premarket: -0.32%

NYSE ended the session with Geo Group jumping 0.8% to $6.33 on Thursday, after two sequential sessions in a row of losses. NYSE jumped 0.9% to $16,614.79, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Geo Group is 1026410, 63.05% below its average volume of 2778150.

Geo Group’s last close was $5.53, 49.73% under its 52-week high of $11.00.

Geo Group’s Sales

Geo Group’s sales growth is a negative 3.5% for the present quarter and a decline by 6.1% for the next. The company’s growth estimates for the present quarter and the next is a negative 154.5% and a negative 17.9%, respectively.

Geo Group’s Revenue

Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.28B for the twelve trailing months.

Geo Group’s Stock Yearly Top and Bottom Value

Geo Group’s stock is valued at $6.33 at 08:34 EST, way under its 52-week high of $11.00 and way above its 52-week low of $4.96.

Geo Group’s Moving Average

Geo Group’s value is below its 50-day moving average of $6.37 and way under its 200-day moving average of $7.39.

More news about Geo Group.

7. Broadcom (AVGOP) – Premarket: -0.25%

NASDAQ ended the session with Broadcom jumping 1.91% to $1,855.54 on Thursday, following the last session’s upward trend. NASDAQ jumped 2.03% to $13,643.59, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Broadcom is 8558, 52.51% below its average volume of 18024.

Broadcom’s last close was $1,855.54, 6.79% under its 52-week high of $1,990.64.

Broadcom’s Revenue

Year-on-year quarterly revenue growth grew by 16.4%, now sitting on 26.51B for the twelve trailing months.

Volatility

Broadcom’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.88%, a positive 0.02%, and a positive 1.61%, respectively.

Broadcom’s highest amplitude of average volatility was 1.42% (last week), 1.38% (last month), and 1.61% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Broadcom’s stock is considered to be oversold (<=20).

Broadcom’s Stock Yearly Top and Bottom Value

Broadcom’s stock is valued at $1,855.54 at 08:34 EST, under its 52-week high of $1,990.64 and way above its 52-week low of $1,327.37.

Broadcom’s Moving Average

Broadcom’s value is above its 50-day moving average of $1,693.57 and way higher than its 200-day moving average of $1,553.59.

More news about Broadcom.

8. Mondelez International (MDLZ) – Premarket: -0.23%

NASDAQ ended the session with Mondelez International rising 0.28% to $63.85 on Thursday while NASDAQ jumped 2.03% to $13,643.59.

Volume

Today’s last reported volume for Mondelez International is 4670330, 46.22% below its average volume of 8685240.

Mondelez International’s last close was $63.85, 8.09% under its 52-week high of $69.47.

Mondelez International’s Sales

Mondelez International’s sales growth is 4% for the present quarter and 7.3% for the next. The company’s growth estimates for the current quarter and the next is 7.5% and 2.6%, respectively.

Mondelez International’s Revenue

Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 28.36B for the twelve trailing months.

Volatility

Mondelez International’s last week, last month’s, and last quarter’s current intraday variation average was 0.38%, 0.34%, and 0.95%, respectively.

Mondelez International’s highest amplitude of average volatility was 0.38% (last week), 0.81% (last month), and 0.95% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Mondelez International’s stock is considered to be oversold (<=20).

Mondelez International’s Stock Yearly Top and Bottom Value

Mondelez International’s stock is valued at $63.85 at 08:34 EST, under its 52-week high of $69.47 and way higher than its 52-week low of $57.63.

Mondelez International’s Moving Average

Mondelez International’s worth is under its 50-day moving average of $64.05 and above its 200-day moving average of $62.98.

More news about Mondelez International.

9. Royalty Pharma (RPRX) – Premarket: -0.21%

NASDAQ ended the session with Royalty Pharma rising 1.51% to $42.44 on Thursday while NASDAQ rose 2.03% to $13,643.59.

Volume

Today’s last reported volume for Royalty Pharma is 2458100, 46.37% above its average volume of 1679350.

Royalty Pharma’s last close was $42.44, 9.89% under its 52-week high of $47.10.

Royalty Pharma’s Sales

Royalty Pharma’s sales growth is a negative 2.7% for the ongoing quarter and 9.3% for the next. The company’s growth estimates for the present quarter and the next is 10% and 4.5%, respectively.

Royalty Pharma’s Revenue

Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.29B for the twelve trailing months.

Volatility

Royalty Pharma’s last week, last month’s, and last quarter’s current intraday variation average was 0.90%, 0.38%, and 1.07%, respectively.

Royalty Pharma’s highest amplitude of average volatility was 0.90% (last week), 0.91% (last month), and 1.07% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Royalty Pharma’s stock is considered to be oversold (<=20).

Royalty Pharma’s Stock Yearly Top and Bottom Value

Royalty Pharma’s stock is valued at $42.44 at 08:34 EST, below its 52-week high of $47.10 and way higher than its 52-week low of $34.86.

Royalty Pharma’s Moving Average

Royalty Pharma’s worth is above its 50-day moving average of $39.22 and above its 200-day moving average of $39.08.

More news about Royalty Pharma.

10. Freeport (FCX) – Premarket: -0.16%

NYSE ended the session with Freeport rising 3.3% to $49.43 on Thursday while NYSE rose 0.9% to $16,614.79.

Volume

Today’s last reported volume for Freeport is 11059200, 41.39% below its average volume of 18869800.

Freeport’s last close was $46.93, 9.73% below its 52-week high of $51.99.

Freeport’s Sales

Freeport’s sales growth is 45% for the ongoing quarter and 28.3% for the next. The company’s growth estimates for the current quarter and the next is 128.2% and 62.7%, respectively.

Freeport’s Revenue

Year-on-year quarterly revenue growth grew by 37.1%, now sitting on 22.84B for the twelve trailing months.

Freeport’s Stock Yearly Top and Bottom Value

Freeport’s stock is valued at $49.43 at 08:34 EST, below its 52-week high of $51.99 and way above its 52-week low of $30.02.

Freeport’s Moving Average

Freeport’s worth is above its 50-day moving average of $45.78 and way higher than its 200-day moving average of $39.38.

More news about Freeport.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here